Pat Treanor

Mr. Patrick Treanor has served as a member of the board since May 2022. Mr. Treanor is the Chief Operating Officer of Pathalys Pharmaceutical, a private biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Prior to Pathalys, Mr. Treanor served as the President of Vifor Pharma North America where he helped the company through the integration of Relypsa Pharmaceuticals and the expansion of its presence and product portfolio in North America. Mr. Treanor had previously served as Senior Vice President and Chief Commercial Officer of Relypsa, helping lead the launch and commercialization strategy for Veltassa® worldwide. Mr. Treanor has more than 25 years of experience building commercial organizations in the biotech, pharmaceutical, and medical device sectors at organizations including Johnson & Johnson, Abbott Laboratories, Oscient Pharmaceuticals, AMAG Pharmaceuticals, and Insulet Corporation. Mr. Treanor received an MBA from Rensselaer Polytechnic Institute and a B.S. in Management from Bryant University.